Anti-GPCR GPR18 antibody,Abcam,AB76258

Target data Receptor for endocannabinoid N-arachidonyl glycine (NAGly) (PubMed : 16844083, PubMed : 24762058, PubMed : 27572937). However, conflicting results about the role of NAGly as an agonist are reported (PubMed : 27018161). Can also be activated by plant-derived and synthetic cannabinoid agonists (PubMed : 24762058). The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase (PubMed : 16844083). May contribute to regulation of the immune system. Is required for normal homeostasis of CD8+ subsets of intraepithelial lymphocytes (IELs) (CD8alphaalpha and CD8alphabeta IELs)in small intstine by supporting preferential migration of CD8alphaalpha T-cells to intraepithelial compartment over lamina propria compartment, and by mediating their reconstitution into small intestine after bone marrow transplant (By similarity). Plays a role in hypotensive responses, mediating reduction in intraocular and blood pressure (By similarity). Mediates NAGly-induced process of reorganization of actin filaments and induction of acrosomal exocytosis (PubMed : 27572937). See full target information GPR18